Inflammatory arthritis

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Inflammatory arthritis is a group of diseases which includes: rheumatoid arthritis, psoriatic arthropathy, inflammatory bowel disease, adult-onset Still's disease, scleroderma, juvenile idiopathic arthritis, and systemic lupus erythematosus (SLE).[1]

Signs and symptoms[edit]

Symptoms of inflammatory arthritis include stiffness, pain, and swelling of the joints, restricted motions, and reduced physical strength. Other symptoms may include systemic complaints including fatigue.[2]

Management[edit]

Treatments for inflammatory arthritis vary by subtype, though they may include drugs like DMARDs (disease-modifying anti-rheumatic drugs) and tumor necrosis factor inhibitors.[2]

Prognosis[edit]

Inflammatory arthritis can be disabling to the point where people with the diseases can lose their jobs, which can cause psychological distress; because it is typically progressive, those who lose their jobs are unlikely to re-enter the workforce after leaving due to their diagnosis. Programs now aim to retain those with inflammatory arthritis by preventing work-related injuries and by making necessary accommodations in the workplace. A 2014 Cochrane review found low-quality evidence that work focused interventions, including counseling, education, advocacy, and occupational medicine consultations, were effective in retaining workers with inflammatory arthritis.[2]

Epidemiology[edit]

The worldwide prevalence of inflammatory arthritis is approximately 3%. Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and undifferentiated spondyloarthritis are the most common subtypes of inflammatory arthritis; the diseases occur most commonly in the 30-40 age group.[2]

References[edit]

  1. ^ Greenstein, Ben Greenstein, Adam (2007). Concise clinical pharmacology. London: Pharmaceutical Press. p. 102. ISBN 978-0853695769.
  2. ^ a b c d Hoving JL, Lacaille D, Urquhart DM, Hannu TJ, Sluiter JK, Frings-Dresen MH (2014). "Non-pharmacological interventions for preventing job loss in workers with inflammatory arthritis". The Cochrane Database of Systematic Reviews. 11 (11): CD010208. doi:10.1002/14651858.CD010208.pub2. PMID 25375291.